StopDownOpen the app

Legal · AI & Deep Tech

Upsurge Labs cancels Bengaluru 'Peptide Party' after FDA intervention

By ·

Date
Company
Upsurge Labs
What it does
biotech incubator and research firm
Kind
Legal
Based in
Bengaluru
Sector
AI & Deep Tech

What they do

Upsurge Labs, a Bengaluru-based biotech incubator, cancelled its 'Peptide Party' event after the Karnataka Food Safety and Drug Administration (FDA) raised…

What happened

The event was intended as an educational meetup for 50 people to discuss peptides, but the FDA requested detailed information on the preparations and their…

Why it matters

The founder, Sowmay Jain, stated the event was meant to promote awareness of peptides and emphasized the need for India to lead in biotech innovation

The details

  • Upsurge Labs, a Bengaluru-based biotech incubator, cancelled its 'Peptide Party' event on 28 August 2026 after the Karnataka Food Safety and Drug Administration (FDA) raised concerns about the unsupervised use of peptides.
  • The event was planned as an invite-only gathering for 50 people to discuss peptides, with discussions on their use in wellness, fitness, longevity, and biohacking.
  • The FDA issued a notice seeking detailed information on the peptide preparations, including their composition, source, regulatory classification, and intended use.
  • The FDA warned that certain peptide preparations may fall under the regulatory framework for drugs under the Drugs and Cosmetics Act, 1940.
  • The FDA requested information on the health claims associated with the peptides, including those related to weight management, muscle growth, and anti-ageing.
  • Upsurge Labs confirmed the cancellation of the event after the FDA's intervention, stating that the event would not proceed without proper regulatory compliance.
  • Sowmay Jain, the founder of Upsurge Labs, described the event as an educational meetup meant to promote awareness of peptides and emphasized the need for India to lead in biotech innovation.

The bigger picture

  • The event raised concerns about the unsupervised use of peptides, some of which may not be safe without medical supervision or a doctor's advice.
  • The FDA requested detailed information on the peptide preparations, including their composition, source, regulatory classification, and intended use.
  • The FDA warned that certain peptide preparations may fall under the regulatory framework for drugs under the Drugs and Cosmetics Act, 1940.
  • The FDA requested information on the health claims associated with the peptides, including those related to weight management, muscle growth, and anti-ageing.

About the business

  • Upsurge Labs is a biotech incubator and research firm based in Bengaluru, India.
  • The company incubates various projects, including Lauki, Zelta, Gulab, Naksha, Helium, Openbio, Banana, Mogra, Bhindi, Moltx, and Anannas.
  • The company focuses on biotechnology and related research, aiming to foster innovation in the field.
  • Upsurge Labs is involved in discussions and research on peptides, which are short chains of amino acids with various functions in the human body.
  • The company's website provides information on its incubated projects and contact details.

The deal

Type
policy

Founders

  • Sowmay Jain, founder
  • Anushka Singh, event host

Other articles talking about it

Read it as a card in the app

Same day

All startup news on 29 August 2026 →